Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
Clinical trial NCT03140722 · TERMINATED
Trial details
- NCT number
- NCT03140722
- Sponsor
- Akebia Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-02
- Primary completion
- 2018-03-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.